This has serious implications since obesity has already been associated with the risk of developing aggressive disease and recurrence due to decreased biopsy and prostate-specific antigen (PSA) efficiency and overall larger prostate size43. This evidence concerns the gene KLK3 and obesity due to melanocortin 4 receptor deficiency.